Articles de revues sur le sujet « Experimental Autoimmune Encephalomyelitis, Progesterone »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Experimental Autoimmune Encephalomyelitis, Progesterone ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Giatti, S., D. Caruso, M. Boraso, et al. "Neuroprotective Effects of Progesterone in Chronic Experimental Autoimmune Encephalomyelitis." Journal of Neuroendocrinology 24, no. 6 (2012): 851–61. http://dx.doi.org/10.1111/j.1365-2826.2012.02284.x.
Texte intégralMilosevic, Ana, Irena Lavrnja, Danijela Savic, et al. "Rat Ovarian Function Is Impaired during Experimental Autoimmune Encephalomyelitis." Cells 12, no. 7 (2023): 1045. http://dx.doi.org/10.3390/cells12071045.
Texte intégralGaray, Laura, Maria Claudia Gonzalez Deniselle, Regine Sitruk-Ware, Rachida Guennoun, Michael Schumacher, and Alejandro F. De Nicola. "Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 276, no. 1-2 (2014): 89–97. http://dx.doi.org/10.1016/j.jneuroim.2014.08.619.
Texte intégralYates, M. A., Y. Li, P. Chlebeck, T. Proctor, A. A. Vandenbark, and H. Offner. "Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 220, no. 1-2 (2010): 136–39. http://dx.doi.org/10.1016/j.jneuroim.2010.01.013.
Texte intégralGaray, L. I., M. C. González Deniselle, M. E. Brocca, A. Lima, P. Roig, and A. F. De Nicola. "Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis." Neuroscience 226 (December 2012): 40–50. http://dx.doi.org/10.1016/j.neuroscience.2012.09.032.
Texte intégralGaray, Laura, Maria Claudia Gonzalez Deniselle, Maria Meyer, et al. "Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis." Brain Research 1283 (August 2009): 177–85. http://dx.doi.org/10.1016/j.brainres.2009.04.057.
Texte intégralUtevska, S. V. "Experimental autoimmune encephalomyelitis (EAE) course in prenatally stressed rat males, the offspring of mothers with different sensitivity to EAE." Faktori eksperimental'noi evolucii organizmiv 24 (August 30, 2019): 244–48. http://dx.doi.org/10.7124/feeo.v24.1109.
Texte intégralMilosevic, Ana, Katarina Milosevic, Anica Zivkovic, et al. "Alterations in the Hypothalamic–Pituitary–Adrenal Axis as a Response to Experimental Autoimmune Encephalomyelitis in Dark Agouti Rats of Both Sexes." Biomolecules 14, no. 8 (2024): 1020. http://dx.doi.org/10.3390/biom14081020.
Texte intégralYu, Hong-jun, Jun Fei, Xing-shu Chen, et al. "Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein." Neuroscience Letters 476, no. 1 (2010): 42–45. http://dx.doi.org/10.1016/j.neulet.2010.03.079.
Texte intégralGhoumari, Abdel Mouman, Charly Abi Ghanem, Narimène Asbelaoui, Michael Schumacher, and Rashad Hussain. "Roles of Progesterone, Testosterone and Their Nuclear Receptors in Central Nervous System Myelination and Remyelination." International Journal of Molecular Sciences 21, no. 9 (2020): 3163. http://dx.doi.org/10.3390/ijms21093163.
Texte intégralEngler, Jan Broder, Nina Kursawe, María Emilia Solano, et al. "Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy." Proceedings of the National Academy of Sciences 114, no. 2 (2017): E181—E190. http://dx.doi.org/10.1073/pnas.1617115114.
Texte intégralGoudarzvand, Mahdi, Yaser Panahi, Reza Yazdani, et al. "The Effects of D-aspartate on Neurosteroids, Neurosteroid Receptors, and Inflammatory Mediators in Experimental Autoimmune Encephalomyelitis." Endocrine, Metabolic & Immune Disorders - Drug Targets 19, no. 3 (2019): 316–25. http://dx.doi.org/10.2174/1871530318666181005093459.
Texte intégralKanellopoulos, Jean. "Experimental autoimmune encephalomyelitis." Biomedical Journal 38, no. 3 (2015): 181. http://dx.doi.org/10.4103/2319-4170.158500.
Texte intégral&NA;. "??? and experimental autoimmune encephalomyelitis." Inpharma Weekly &NA;, no. 1051 (1996): 8. http://dx.doi.org/10.2165/00128413-199610510-00018.
Texte intégralGlynn, P., D. Weedon, and M. L. Cuzner. "Chronic experimental autoimmune encephalomyelitis." Journal of the Neurological Sciences 73, no. 1 (1986): 111–23. http://dx.doi.org/10.1016/0022-510x(86)90069-9.
Texte intégralHEININGER, KURT, WALTER FIERZ, BÄRBEL SCHÄFER, HANS-PETER HARTUNG, and KLAUS V. TOYKA. "Adoptive Transfer Experimental Autoimmune Encephalomyelitis." Annals of the New York Academy of Sciences 540, no. 1 Advances in N (1988): 738–40. http://dx.doi.org/10.1111/j.1749-6632.1988.tb27231.x.
Texte intégralDal Canto, R., G. Costa, L. Steinman, M. Dal Canto, and C. G. Fathman. "Experimental “autoimmune” versus “allergic” encephalomyelitis." Journal of Neuroimmunology 90, no. 1 (1998): 4. http://dx.doi.org/10.1016/s0165-5728(98)91215-2.
Texte intégralWeedon, D., P. Glynn, and M. L. Cuzner. "Chronic relapsing experimental autoimmune encephalomyelitis." Journal of the Neurological Sciences 72, no. 2-3 (1986): 255–63. http://dx.doi.org/10.1016/0022-510x(86)90013-4.
Texte intégralW., Li, L. Quigley, D. L. Yao, et al. "Chronic Relapsing Experimental Autoimmune Encephalomyelitis." Journal of Neuropathology and Experimental Neurology 57, no. 5 (1998): 426–38. http://dx.doi.org/10.1097/00005072-199805000-00006.
Texte intégralVarriale, S., E. Béraud, D. Brandli, J. Barbaria, M. M. Golstein, and D. Bernard. "Regulation of experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 22, no. 1 (1989): 31–40. http://dx.doi.org/10.1016/0165-5728(89)90006-4.
Texte intégralSternberg, Z., A. Cesario, K. Rittenhouse-Olson, et al. "Acamprosate modulates experimental autoimmune encephalomyelitis." Inflammopharmacology 20, no. 1 (2011): 39–48. http://dx.doi.org/10.1007/s10787-011-0097-1.
Texte intégralAnderton, StephenM. "Peptide immunotherapy in experimental autoimmune encephalomyelitis." Biomedical Journal 38, no. 3 (2015): 206. http://dx.doi.org/10.4103/2319-4170.158510.
Texte intégralNam, Ki Hoan. "Experimental autoimmune encephalomyelitis in cynomolgus monkeys." Journal of Veterinary Science 1, no. 2 (2000): 127. http://dx.doi.org/10.4142/jvs.2000.1.2.127.
Texte intégralFeinstein, D. L., C. F. Brosnan, C. C. Whitacre, G. E. Landreth, V. Gavrilyuk, and M. T. Heneka. "PPAR-agonists prevent experimental autoimmune encephalomyelitis." Journal of Neurochemistry 81 (June 28, 2008): 36. http://dx.doi.org/10.1046/j.1471-4159.81.s1.81.x.
Texte intégralRodrigues, David Henrique, Daniela Sachs, and Antonio Lucio Teixeira. "Mechanical hypernociception in experimental autoimmune encephalomyelitis." Arquivos de Neuro-Psiquiatria 67, no. 1 (2009): 78–81. http://dx.doi.org/10.1590/s0004-282x2009000100019.
Texte intégralNovikova, Natalia S., Anastasia S. Diatlova, Kristina Z. Derevtsova, et al. "Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 337 (December 2019): 577070. http://dx.doi.org/10.1016/j.jneuroim.2019.577070.
Texte intégralWHITACRE, CAROLINE C., KENNICHI DOWDELL, and ANN C. GRIFFIN. "Neuroendocrine Influences on Experimental Autoimmune Encephalomyelitis." Annals of the New York Academy of Sciences 840, no. 1 (1998): 705–16. http://dx.doi.org/10.1111/j.1749-6632.1998.tb09609.x.
Texte intégralPollak, Yehuda, Haim Ovadia, Inbal Goshen, et al. "Behavioral aspects of experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 104, no. 1 (2000): 31–36. http://dx.doi.org/10.1016/s0165-5728(99)00257-x.
Texte intégralPelfrey, Clara M., Frank J. Waxman, and Caroline C. Whitacre. "Genetic resistance in experimental autoimmune encephalomyelitis." Cellular Immunology 122, no. 2 (1989): 504–16. http://dx.doi.org/10.1016/0008-8749(89)90096-8.
Texte intégralBaker, David, and Sandra Amor. "Quality control of experimental autoimmune encephalomyelitis." Multiple Sclerosis Journal 16, no. 9 (2010): 1025–27. http://dx.doi.org/10.1177/1352458510378317.
Texte intégralInada, Rino, Katsuichi Miyamoto, Noriko Tanaka, Kota Moriguchi, and Susumu Kusunoki. "Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis." Internal Medicine 59, no. 1 (2020): 55–60. http://dx.doi.org/10.2169/internalmedicine.3030-19.
Texte intégralWHITACRE, CAROLINE C., INGRID E. GIENAPP, ABBIE MEYER, KAREN L. COX, and NAJMA JAVED. "Oral Tolerance in Experimental Autoimmune Encephalomyelitis." Annals of the New York Academy of Sciences 778, no. 1 (1996): 217–27. http://dx.doi.org/10.1111/j.1749-6632.1996.tb21130.x.
Texte intégralJAVED, NAJMA H., INGRID GIENAPP, KAREN COX, and CAROLINE C. WHITACRE. "Oral Tolerance in Experimental Autoimmune Encephalomyelitis." Annals of the New York Academy of Sciences 778, no. 1 (1996): 393–94. http://dx.doi.org/10.1111/j.1749-6632.1996.tb21154.x.
Texte intégralBernstein, Alison I., and Gary W. Miller. "Oxidative Signaling in Experimental Autoimmune Encephalomyelitis." Toxicological Sciences 114, no. 2 (2010): 159–61. http://dx.doi.org/10.1093/toxsci/kfq012.
Texte intégralUeno, Rino, Katsuichi Miyamoto, Noriko Tanaka, Kota Moriguchi, Kenji Kadomatsu, and Susumu Kusunoki. "Keratan sulfate exacerbates experimental autoimmune encephalomyelitis." Journal of Neuroscience Research 93, no. 12 (2015): 1874–80. http://dx.doi.org/10.1002/jnr.23640.
Texte intégralSwanborg, R. H., K. E. Gould, and J. A. Stepaniak. "Studies of experimental autoimmune encephalomyelitis (EAE)." Journal of Immunology 153, no. 5 (1994): 2352. http://dx.doi.org/10.4049/jimmunol.153.5.2352.
Texte intégralHoffman, Kristina R., David P. Daberkow, Hannah M. Kohl, Tyrel Long, Trevor O. Kirby, and Javier Ochoa-Reparaz. "Microbiome methods in experimental autoimmune encephalomyelitis." Journal of Immunology 208, no. 1_Supplement (2022): 158.13. http://dx.doi.org/10.4049/jimmunol.208.supp.158.13.
Texte intégralHou, Lifei, Florian Winau, and Eileen Remold-O’Donnell. "SerpinB1 Deficiency Ameliorates Experimental Autoimmune Encephalomyelitis." Journal of Immunology 196, no. 1_Supplement (2016): 58.13. http://dx.doi.org/10.4049/jimmunol.196.supp.58.13.
Texte intégralVarriale, S., E. Béraud, J. Barbaria, R. Galibert, and D. Bernard. "Regulation of experimental autoimmune encephalomyelitis: Inhibition of adoptive experimental autoimmune encephalomyelitis by ‘recovery-associated suppressor cells’." Journal of Neuroimmunology 53, no. 2 (1994): 123–31. http://dx.doi.org/10.1016/0165-5728(94)90022-1.
Texte intégralShin, Taekyun, Meejung Ahn, Changjong Moon, and Seungjoon Kim. "Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis." Anatomy & Cell Biology 45, no. 4 (2012): 215. http://dx.doi.org/10.5115/acb.2012.45.4.215.
Texte intégralAhn, Meejung, Jeongtae Kim, Wonjun Yang, et al. "Amelioration of experimental autoimmune encephalomyelitis byIshige okamurae." Anatomy & Cell Biology 51, no. 4 (2018): 292. http://dx.doi.org/10.5115/acb.2018.51.4.292.
Texte intégralDe Sarno, Patrizia, Robert C. Axtell, Chander Raman, Kevin A. Roth, Dario R. Alessi, and Richard S. Jope. "Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis." Journal of Immunology 181, no. 1 (2008): 338–45. http://dx.doi.org/10.4049/jimmunol.181.1.338.
Texte intégralTheil, Michael-Mark, Sachiko Miyake, Miho Mizuno, et al. "Suppression of Experimental Autoimmune Encephalomyelitis by Ghrelin." Journal of Immunology 183, no. 4 (2009): 2859–66. http://dx.doi.org/10.4049/jimmunol.0803362.
Texte intégralMausner-Fainberg, Karin. "Eotaxin-2 blockade ameliorates experimental autoimmune encephalomyelitis." World Journal of Immunology 3, no. 1 (2013): 7. http://dx.doi.org/10.5411/wji.v3.i1.7.
Texte intégralMurugaiyan, Gopal, Vanessa Beynon, Akanksha Mittal, Nicole Joller, and Howard L. Weiner. "Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis." Journal of Immunology 187, no. 5 (2011): 2213–21. http://dx.doi.org/10.4049/jimmunol.1003952.
Texte intégralLe, Thuong Manh, Mika Takarada-Iemata, Hieu Minh Ta, et al. "Ndrg2deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis." Journal of Neurochemistry 145, no. 2 (2018): 139–53. http://dx.doi.org/10.1111/jnc.14294.
Texte intégralPiccio, Laura, Jennifer L. Stark, and Anne H. Cross. "Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis." Journal of Leukocyte Biology 84, no. 4 (2008): 940–48. http://dx.doi.org/10.1189/jlb.0208133.
Texte intégralNamiki, Kana, Hirofumi Matsunaga, Kento Yoshioka та ін. "Mechanism for p38α-mediated Experimental Autoimmune Encephalomyelitis". Journal of Biological Chemistry 287, № 29 (2012): 24228–38. http://dx.doi.org/10.1074/jbc.m111.338541.
Texte intégralProsiegel, M., I. Neu, S. Vogl, G. Hoffmann, A. Wildfeuer, and G. Ruhenstroth-Bauer. "Suppression of experimental autoimmune encephalomyelitis by sulfasalazine." Acta Neurologica Scandinavica 81, no. 3 (2009): 237–38. http://dx.doi.org/10.1111/j.1600-0404.1990.tb00973.x.
Texte intégralBATOULIS, HELENA, MASCHA S. RECKS, KLAUS ADDICKS, and STEFANIE KUERTEN. "Experimental autoimmune encephalomyelitis - achievements and prospective advances." APMIS 119, no. 12 (2011): 819–30. http://dx.doi.org/10.1111/j.1600-0463.2011.02794.x.
Texte intégral